HAYWARD, Calif.--(BUSINESS WIRE)--Global Pharmaceuticals, the generic products division of Impax Laboratories, Inc. (NASDAQ: IPXL), today announced their cooperation in awarding a modest grant to Myasthenia Gravis Alliance, also known as Myasthenia Gravis Foundation of Greater New York, Inc., a 501(3)(c) non profit membership corporation, incorporated in the State of New York. A portion of the grant will fund The Alliance Fellowship for Myasthenia Gravis Research, at the University of California, Davis, under the direction of Dr. Robert Fairclough, Faculty Researcher/ Principal Investigator. The remainder of the grant will help defer the cost of The Circle News and other operating items.
